Steroid-Induced Osteonecrosis in Dermatology: A Review.

BACKGROUND

Steroid-induced osteonecrosis is unpredictable and highly morbid.

METHODS

MEDLINE (Ovid) and PubMed search for relevant literature.

RESULTS

Oral steroid doses typically considered to be associated with the condition are >20 mg of prednisone (or equivalent) per day or >2 g within a period of 2 to 3 months. Symptoms may be vague.

CONCLUSIONS

Dermatologists must exercise a high degree of clinical suspicion and warn patients about steroid-related risks and conditions for follow-up.